New BNP blood test could improve heart failure diagnosis

NCT ID NCT07217431

Completed Diagnosis Sponsor: Beckman Coulter, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new BNP blood test on 1,361 people to see how well it identifies heart failure. The test measures a substance in the blood that can indicate heart strain. Researchers compared the test results to standard methods to check accuracy. The goal is to give doctors a reliable tool for diagnosing heart failure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BNP blood test
What this could lead to: If successful, this could provide a more accurate and reliable blood test to help doctors diagnose heart failure.
What could go wrong: This is a completed study focused on test accuracy, not a treatment. The test may not perform as well in real-world settings or different patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

HealthPartners Central Laboratory

Eden Prairie, Minnesota, 55344, United States
Hennepin Healthcare Research Institute

Minneapolis, Minnesota, 55404, United States
University of Maryland-Baltimore

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.